I
1.38
-0.07 (-4.83%)
| Penutupan Terdahulu | 1.45 |
| Jumlah Dagangan | 203,566 |
| Harga / Buku (P/B) | 1.96 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -19,810.00% |
| EPS Cair (TTM) | -1.93 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 257.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.17% |
| Nisbah Semasa (MRQ) | 2.64 |
| Aliran Tunai Operasi (OCF TTM) | -32.71 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -18.16 M |
| Pulangan Atas Aset (ROA TTM) | -61.33% |
| Pulangan Atas Ekuiti (ROE TTM) | -139.01% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | INmune Bio Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 0.0 |
| Persekitaran Makro | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.69 |
|
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 24.61% |
| % Dimiliki oleh Institusi | 27.95% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Raymond James Financial Inc | 30 Jun 2026 | 212,995 |
| Westside Investment Management, Inc. | 30 Jun 2026 | 108,300 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |